Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 188

1.

Reply: The future of radiopeptide therapy in patients with progressive meningioma.

Radojewski P, Dumont R, Manrincek N, Brunner P, Müller-Brand J, Maecke H, Briel M, Walter MA.

J Nucl Med. 2016 Jun 30. pii: jnumed.116.178145. [Epub ahead of print] No abstract available.

PMID:
27363835
2.

Agreements between Industry and Academia on Publication Rights: A Retrospective Study of Protocols and Publications of Randomized Clinical Trials.

Kasenda B, von Elm E, You JJ, Blümle A, Tomonaga Y, Saccilotto R, Amstutz A, Bengough T, Meerpohl JJ, Stegert M, Olu KK, Tikkinen KA, Neumann I, Carrasco-Labra A, Faulhaber M, Mulla SM, Mertz D, Akl EA, Bassler D, Busse JW, Ferreira-González I, Lamontagne F, Nordmann A, Gloy V, Raatz H, Moja L, Ebrahim S, Schandelmaier S, Sun X, Vandvik PO, Johnston BC, Walter MA, Burnand B, Schwenkglenks M, Hemkens LG, Bucher HC, Guyatt GH, Briel M.

PLoS Med. 2016 Jun 28;13(6):e1002046. doi: 10.1371/journal.pmed.1002046. eCollection 2016 Jun.

3.

FOXC2 disease-mutations identified in lymphedema-distichiasis patients cause both loss and gain of protein function.

Tavian D, Missaglia S, Maltese PE, Michelini S, Fiorentino A, Ricci M, Serrani R, Walter MA, Bertelli M.

Oncotarget. 2016 Jun 2. doi: 10.18632/oncotarget.9797. [Epub ahead of print]

4.

Prostaglandins in the eye: Function, expression, and roles in glaucoma.

Doucette LP, Walter MA.

Ophthalmic Genet. 2016 Apr 12:1-9. [Epub ahead of print]

PMID:
27070211
5.

Novel PITX2 gene mutations in patients with Axenfeld-Rieger syndrome.

Seifi M, Footz T, Taylor SA, Elhady GM, Abdalla EM, Walter MA.

Acta Ophthalmol. 2016 Mar 24. doi: 10.1111/aos.13030. [Epub ahead of print]

PMID:
27009473
6.

Planning and reporting of quality-of-life outcomes in cancer trials.

Schandelmaier S, Conen K, von Elm E, You JJ, Blümle A, Tomonaga Y, Saccilotto R, Amstutz A, Bengough T, Meerpohl JJ, Stegert M, Olu KK, Tikkinen KA, Neumann I, Carrasco-Labra A, Faulhaber M, Mulla SM, Mertz D, Akl EA, Sun X, Bassler D, Busse JW, Ferreira-González I, Lamontagne F, Nordmann A, Gloy V, Raatz H, Moja L, Rosenthal R, Ebrahim S, Vandvik PO, Johnston BC, Walter MA, Burnand B, Schwenkglenks M, Hemkens LG, Bucher HC, Guyatt GH, Briel M, Kasenda B; DISCO study group.

Ann Oncol. 2016 Jan;27(1):209. doi: 10.1093/annonc/mdv559. Epub 2015 Nov 25. No abstract available.

PMID:
26612098
7.

On transcending the impasse of respiratory motion correction applications in routine clinical imaging - a consideration of a fully automated data driven motion control framework.

Kesner AL, Schleyer PJ, Büther F, Walter MA, Schäfers KP, Koo PJ.

EJNMMI Phys. 2014 Dec;1(1):8. doi: 10.1186/2197-7364-1-8. Epub 2014 Jun 17.

8.

Premature Discontinuation of Randomized Trials in Critical and Emergency Care: A Retrospective Cohort Study.

Schandelmaier S, von Elm E, You JJ, Blümle A, Tomonaga Y, Lamontagne F, Saccilotto R, Amstutz A, Bengough T, Meerpohl JJ, Stegert M, Olu KK, Tikkinen KA, Neumann I, Carrasco-Labra A, Faulhaber M, Mulla SM, Mertz D, Akl EA, Sun X, Bassler D, Busse JW, Ferreira-González I, Nordmann A, Gloy V, Raatz H, Moja L, Rosenthal R, Ebrahim S, Vandvik PO, Johnston BC, Walter MA, Burnand B, Schwenkglenks M, Hemkens LG, Cook DJ, Meade MO, Bucher HC, Kasenda B, Briel M.

Crit Care Med. 2016 Jan;44(1):130-7. doi: 10.1097/CCM.0000000000001369.

PMID:
26468895
9.

Planning and reporting of quality-of-life outcomes in cancer trials.

Schandelmaier S, Conen K, von Elm E, You JJ, Blümle A, Tomonaga Y, Saccilotto, Amstutz A, Bengough T, Meerpohl JJ, Stegert M, Olu KK, Tikkinen KA, Neumann I, Carrasco-Labra A, Faulhaber M, Mulla SM, Mertz D, Akl EA, Sun X, Bassler D, Busse JW, Ferreira-González I, Lamontagne F, Nordmann A, Gloy V, Raatz H, Moja L, Rosenthal R, Ebrahim S, Vandvik PO, Johnston BC, Walter MA, Burnand B, Schwenkglenks M, Hemkens LG, Bucher HC, Guyatt GH, Briel M, Kasenda B; DISCO study group.

Ann Oncol. 2015 Sep;26(9):1966-73. doi: 10.1093/annonc/mdv283. Epub 2015 Jun 30. Erratum in: Ann Oncol. 2016 Jan;27(1):209.

PMID:
26133966
10.

The interactions of genes, age, and environment in glaucoma pathogenesis.

Doucette LP, Rasnitsyn A, Seifi M, Walter MA.

Surv Ophthalmol. 2015 Jul-Aug;60(4):310-26. doi: 10.1016/j.survophthal.2015.01.004. Epub 2015 Feb 4. Review.

PMID:
25907525
11.

Towards tailored radiopeptide therapy.

Radojewski P, Dumont R, Marincek N, Brunner P, Mäcke HR, Müller-Brand J, Briel M, Walter MA.

Eur J Nucl Med Mol Imaging. 2015 Jul;42(8):1231-7. doi: 10.1007/s00259-015-3030-9. Epub 2015 Mar 20.

PMID:
25792454
12.

[Peptide receptor radionuclide therapy for patients with somatostatin receptor expressing tumours. German Guideline (S1)].

Poeppel TD, Boy C, Bockisch A, Kotzerke J, Buchmann I, Ezziddin S, Scheidhauer K, Krause BJ, Schmidt D, Amthauer H, Rösch F, Nagarajah J, Führer D, Lahner H, Pöpperl G, Hörsch D, Walter MA, Baum RP.

Nuklearmedizin. 2015;54(1):1-11; quiz N2. German.

PMID:
25683107
13.

Survival after somatostatin based radiopeptide therapy with (90)Y-DOTATOC vs. (90)Y-DOTATOC plus (177)Lu-DOTATOC in metastasized gastrinoma.

Dumont RA, Seiler D, Marincek N, Brunner P, Radojewski P, Rochlitz C, Müller-Brand J, Maecke HR, Briel M, Walter MA.

Am J Nucl Med Mol Imaging. 2014 Dec 15;5(1):46-55. eCollection 2015.

14.

Somatostatin receptor-targeted radiopeptide therapy with 90Y-DOTATOC and 177Lu-DOTATOC in progressive meningioma: long-term results of a phase II clinical trial.

Marincek N, Radojewski P, Dumont RA, Brunner P, Müller-Brand J, Maecke HR, Briel M, Walter MA.

J Nucl Med. 2015 Feb;56(2):171-6. doi: 10.2967/jnumed.114.147256. Epub 2015 Jan 15.

15.

18F-RB390: innovative ligand for imaging the T877A androgen receptor mutant in prostate cancer via positron emission tomography (PET).

Bertolini R, Goepfert C, Andrieu T, Nichols S, Walter MA, Frey FJ, McCammon JA, Frey BM.

Prostate. 2015 Mar 1;75(4):348-59. doi: 10.1002/pros.22919. Epub 2014 Oct 30.

PMID:
25358634
16.

Subgroup analyses in randomised controlled trials: cohort study on trial protocols and journal publications.

Kasenda B, Schandelmaier S, Sun X, von Elm E, You J, Blümle A, Tomonaga Y, Saccilotto R, Amstutz A, Bengough T, Meerpohl JJ, Stegert M, Olu KK, Tikkinen KA, Neumann I, Carrasco-Labra A, Faulhaber M, Mulla SM, Mertz D, Akl EA, Bassler D, Busse JW, Ferreira-González I, Lamontagne F, Nordmann A, Gloy V, Raatz H, Moja L, Rosenthal R, Ebrahim S, Vandvik PO, Johnston BC, Walter MA, Burnand B, Schwenkglenks M, Hemkens LG, Bucher HC, Guyatt GH, Briel M; DISCO Study Group.

BMJ. 2014 Jul 16;349:g4539. doi: 10.1136/bmj.g4539. Erratum in: BMJ. 2014;349:4921. Kasenda, Benjamin [added]; Schandelmaier, Stefan [added]; Sun, Xin [added]; von Elm, Erik [added]; You, John [added]; Blümle, Anette [added]; Tomonaga, Yuki (8) Saccilotto, Ramon (9) Amstutz, Alain [added]; Bengough, Theresa [added]; etc..

17.

Completion and Publication Rates of Randomized Controlled Trials in Surgery: An Empirical Study.

Rosenthal R, Kasenda B, Dell-Kuster S, von Elm E, You J, Blümle A, Tomonaga Y, Saccilotto R, Amstutz A, Bengough T, Meerpohl JJ, Stegert M, Tikkinen KA, Neumann I, Carrasco-Labra A, Faulhaber M, Mulla S, Mertz D, Akl EA, Bassler D, Busse JW, Ferreira-González I, Lamontagne F, Nordmann A, Gloy V, Olu KK, Raatz H, Moja L, Ebrahim S, Schandelmaier S, Sun X, Vandvik PO, Johnston BC, Walter MA, Burnand B, Schwenkglenks M, Hemkens LG, Bucher HC, Guyatt GH, Briel M.

Ann Surg. 2015 Jul;262(1):68-73. doi: 10.1097/SLA.0000000000000810.

PMID:
24979608
18.

Indium-111 labeled gold nanoparticles for in-vivo molecular targeting.

Ng QK, Olariu CI, Yaffee M, Taelman VF, Marincek N, Krause T, Meier L, Walter MA.

Biomaterials. 2014 Aug;35(25):7050-7. doi: 10.1016/j.biomaterials.2014.04.098. Epub 2014 May 17.

PMID:
24840614
19.

FOXA1 deletion in luminal epithelium causes prostatic hyperplasia and alteration of differentiated phenotype.

DeGraff DJ, Grabowska MM, Case TC, Yu X, Herrick MK, Hayward WJ, Strand DW, Cates JM, Hayward SW, Gao N, Walter MA, Buttyan R, Yi Y, Kaestner KH, Matusik RJ.

Lab Invest. 2014 Jul;94(7):726-39. doi: 10.1038/labinvest.2014.64. Epub 2014 May 19.

20.

Prevalence, characteristics, and publication of discontinued randomized trials.

Kasenda B, von Elm E, You J, Blümle A, Tomonaga Y, Saccilotto R, Amstutz A, Bengough T, Meerpohl JJ, Stegert M, Tikkinen KA, Neumann I, Carrasco-Labra A, Faulhaber M, Mulla SM, Mertz D, Akl EA, Bassler D, Busse JW, Ferreira-González I, Lamontagne F, Nordmann A, Gloy V, Raatz H, Moja L, Rosenthal R, Ebrahim S, Schandelmaier S, Xin S, Vandvik PO, Johnston BC, Walter MA, Burnand B, Schwenkglenks M, Hemkens LG, Bucher HC, Guyatt GH, Briel M.

JAMA. 2014 Mar 12;311(10):1045-51. doi: 10.1001/jama.2014.1361.

PMID:
24618966
Items per page

Supplemental Content

Loading ...
Write to the Help Desk